Brind.

The American Psychiatric Association stated that FDA criteria are too limiting for the use of biomarkers in clinical settings.

1 report, 1 independent Updated Oct 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The American Psychiatric Association stated that FDA criteria are too limiting for the use of biomarkers in clinical settings.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped